npj Digital Medicine· 2026Q1· Review
A scoping review of digital health technologies in glycogen storage diseases
- 0citations
- Q1SCImago
- 2026year
Short summary
A scoping review of 44 studies reveals digital health technologies (DHTs) are primarily used for glucose monitoring (66%) in glycogen storage diseases (GSDs), with a focus on hepatic subtypes and limited research on muscle subtypes, movement behavior, or psychosocial aspects.
AI-generated from the title and abstract; the full text is not read.
Key points
- 44 studies on DHTs in GSDs were identified, covering 17 subtypes and 662 participants.
- Continuous glucose monitoring (CGM) was the most common DHT, used in 66% of studies.
- Research is concentrated in Europe (48%) and primarily focuses on hepatic GSD subtypes (59%).
- Significant research gaps exist in muscle GSD subtypes, movement behavior, and psychosocial evaluation.
- Current DHT use in GSD research is largely glucose-centric, neglecting holistic health monitoring.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Glycogen storage diseases (GSDs) are rare inherited metabolic disorders requiring complex management. Digital health technologies (DHTs) offer solutions for improving care delivery, yet their implementation remains poorly characterised. This scoping review systematically mapped DHT applications in GSDs following PRISMA-ScR guidelines, searching four databases through June 2026. We identified 44 studies with 662 participants across 17 GSD subtypes, revealing geographic concentration in Europe (48%), focus on hepatic subtypes (59%), and predominant use of continuous glucose monitoring (CGM) (66%). Five themes of DHT in GSD research emerged: intervention evaluation, communication enhancement, clinical monitoring, population surveillance, and technology development. Critical gaps included underrepresentation of muscle subtypes and minimal research in movement behaviour and psychosocial evaluation. Glucose-centric DHT use predominates in research; whilst clinically valuable, this neglects holistic health monitoring. Future research should prioritise comprehensive digital ecosystems integrating metabolic, behavioural, and psychosocial monitoring to optimise care for all individuals with GSDs.
The authors' abstract, as published at the source. npj Digital Medicine, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Rheumatology
RheumatologyMedicine